With the developed primer in the assay being able to recognize another frequently found BRAF V600K mutation (GTG > AAG), the performance of the assay in detecting the V600K mutation was also evaluated using genomic DNA from V600K-positive melanoma cell line, LM-MEL-42 (V600K heterozygote). This evidence concerns the gene BRAF and melanoma.